Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification
Published on: October 11, 2024
Characterization and biodistribution of under-employed gene therapy vector AAV7
Samantha A Yost1, Emre Firlar2, Justin D Glenn1
1Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA.
Adeno-associated viruses (AAVs) are promising gene delivery vectors for treating human diseases. Exploring less-studied AAV capsids could reveal unique properties for improved gene therapy applications.
Area of Science:
- Gene therapy
- Viral vector technology
- Molecular biology
Background:
- Adeno-associated viruses (AAVs) are extensively studied for gene delivery.
- Over 100 natural AAV capsid variants exist, classified phylogenetically.
- Well-known AAVs like AAV8 and AAV9 are in clinical use.
Purpose of the Study:
- To explore the potential of less-studied adeno-associated virus (AAV) capsids.
- To identify novel AAV capsids with unique therapeutic properties.
- To expand the knowledge base of AAV capsid structure-function relationships.
Main Methods:
- Phylogenetic classification of AAV capsid sequences.
- Analysis of structure-function relationships for AAV capsids.
- Characterization of properties like potency and tissue tropism for novel capsids.
Main Results:
- Identification of numerous less-studied AAV capsid variants.
- Potential for unique properties such as altered potency and tissue tropism.
- Foundation for understanding capsid engineering and novel applications.
Conclusions:
- Less-studied AAV capsids represent a valuable resource for gene therapy.
- Further research can unlock novel therapeutic applications through capsid engineering.
- Expanding the AAV capsid library enhances gene delivery strategies.
More Related Videos
21:55Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022